Your session is about to expire
← Back to Search
Unknown
BGE-175 for Coronavirus
Phase 2
Waitlist Available
Led By Richard G Wilkerson, MD
Research Sponsored by BioAge Labs, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ability to voluntarily provide informed consent that is documented per local requirements
An understanding, ability, and willingness to fully comply with study procedures and restrictions
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline through day 57; at day 14, day 28 and day 57
Awards & highlights
Study Summary
This study is evaluating whether a drug may help treat people with a certain type of pneumonia.
Eligible Conditions
- Coronavirus
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline through day 57; at day 14, day 28 and day 57
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline through day 57; at day 14, day 28 and day 57
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of Participants Who Have Died or Progressed to Respiratory Failure
Secondary outcome measures
Daily Ratio of Oxygen Saturation (SpO2) to Fractional Inspired O2 (SpO2/FiO2)
Duration of Intubation
Duration of Mechanical Ventilation
+20 moreOther outcome measures
Activity of prostaglandin D2
Concentration of BGE-175
Measure of Inflammation Markers
+3 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: BGE-175Experimental Treatment1 Intervention
BGE-175 tablet to be taken by mouth once a day for 14 days
Group II: PlaceboPlacebo Group1 Intervention
Placebo tablet to be taken by mouth once a day for 14 days
Find a Location
Who is running the clinical trial?
BioAge Labs, Inc.Lead Sponsor
3 Previous Clinical Trials
16 Total Patients Enrolled
Richard G Wilkerson, MDPrincipal InvestigatorUniversity of Maryland Medical Center
2 Previous Clinical Trials
120 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger